136 related articles for article (PubMed ID: 6437739)
1. Vitamin metabolism and the effects of multivitamin supplementation in oral contraceptive users.
Amatayakul K; Uttaravichai C; Singkamani R; Ruckphaopunt S
Contraception; 1984 Aug; 30(2):179-96. PubMed ID: 6437739
[TBL] [Abstract][Full Text] [Related]
2. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Godsland IF; Crook D; Devenport M; Wynn V
Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
[TBL] [Abstract][Full Text] [Related]
3. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
5. Serum vitamin A and retinol-binding protein in malnourished women treated with oral contraceptives: effects of estrogen dose and duration of treatment.
Mohan Ram M; Bamji MS
Am J Obstet Gynecol; 1979 Oct; 135(4):470-2. PubMed ID: 573554
[TBL] [Abstract][Full Text] [Related]
6. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
[TBL] [Abstract][Full Text] [Related]
7. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
Skouby SO; Wagner HH; Andersen O
Contraception; 1983 Nov; 28(5):489-99. PubMed ID: 6425010
[TBL] [Abstract][Full Text] [Related]
8. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS
Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546
[TBL] [Abstract][Full Text] [Related]
10. Hemorheological effects of oral contraceptives.
Ernst E; Schmölzl C; Matrai A; Schramm W
Contraception; 1989 Nov; 40(5):571-80. PubMed ID: 2692965
[TBL] [Abstract][Full Text] [Related]
11. Effect of the administration of vitamin B6 at two levels of intake on xanthurenic acid excretion among oral contraceptive pill users.
el-Sahwy S; Osman M; el-Tabakh S; Khamis Y; Amine AK
J Egypt Public Health Assoc; 1988; 63(5-6):393-405. PubMed ID: 2979953
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
13. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral contraceptive agents on nutrients: II. Vitamins.
Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
[TBL] [Abstract][Full Text] [Related]
15. The effect of oral contraceptives on protein metabolism.
Amatayakul K; Laokuldilok T; Koottathep S; Dejsarai W; Prapamontol T; Srirak N; Tansuhaj A; Uttaravichai C
J Med Assoc Thai; 1994 Oct; 77(10):509-16. PubMed ID: 7745371
[TBL] [Abstract][Full Text] [Related]
16. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
Fruzzetti F; Ricci C; Fioretti P
Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
[TBL] [Abstract][Full Text] [Related]
17. Disturbance of tryptophan metabolism and its correction during hormonal contraception.
Bennink HJ; Schreurs WH
Contraception; 1974 Apr; 9(4):347-56. PubMed ID: 4442280
[TBL] [Abstract][Full Text] [Related]
18. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
Hausmann L; Goebel KM; Zehner J
Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
[TBL] [Abstract][Full Text] [Related]
19. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
[TBL] [Abstract][Full Text] [Related]
20. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]